Post

Open-label extension study of #leniolisib in activated PI3Kδ syndrome: Long-term efficacy and safety. New study from V. Koneti Rao, Gulbu Uzel @charlesuni.cuni.cz and colleagues: rupress.org/jhi/article/... #InbornErrorsOfImmunity